cGxP.wire https://validator.w3.org/feed/docs/rss2.html Nuvation Bio Strengthens Oncology Pipeline with IBTROZI and Safusidenib Advances Regeneron & Sanofi Secure FDA Approval for Dupixent in Pediatric CSU Dogwood Therapeutics Secures $100M Partnership for Antiviral Assets Atrium Therapeutics Earns $15M Milestone from Bristol Myers Squibb Philips Launches Bridge Plus for Critical Cardiac Safety RenovoRx Showcases TAMP Platform Data at ASCO 2026 Repertoire Immune Medicines Doses First Patient in Phase 1/2 Trial InVita HemaConnect 2.5 Boosts CGT Donor Recruitment Monopar ALXN1840 Phase 3 Data Improves Wilson Disease Outcomes Aspira Women’s Health Expands Lab to Advance ENDOinform Test AstraZeneca’s Ultomiris Shows Phase 3 Breakthrough in IgAN Mozart Therapeutics Shows Disease-Modifying Potential in Phase 1 Trial Utepreva Secures FDA Clearance for Advanced Endometrial Sampler Biotia Validates AI-NGS Test for Accurate UTI Detection DemeRx Gains FDA IND Clearance for DMX-1001 in AUD Astrin Earns CAP for Breast Cancer Blood Test Launch Apotex Expands U.S. Portfolio via Cumberland Deal Cipla Strengthens Global Pharma Leadership and Access Sonorous Neurovascular Advances Care with BosCATH Approval Genentech Reports Strong Phase 3 Enspryng Data in MOGAD Philips Boosts Cancer Imaging with Rembra FDA Clearance Merck Partners with Google Cloud for $1B AI Platform Akeso Cadonilimab Combo Shows Strong Survival in Pancreatic Cancer Insilico Medicine Launches Longevity Board for AI Drug Discovery Abbisko Pimicotinib NDA Progress Advances TGCT Therapy Phanes Therapeutics Shows Progress in PDAC with Spevatamig Ipsen Wins EU Approval for Ojemda in Pediatric Glioma Amneal Accelerates Growth with Kashiv BioSciences Deal Regeneron Cemdisiran Shows Strong gMG Phase 3 Results Sanofi Secures FDA Approval for Tzield in Young T1D Merck FDA Approval of IDVYNSO HIV Treatment Drug Neurocrine Shows CRENESSITY Sustains CAH Control Data Vicore Pharma Completes ASPIRE Trial Enrollment in IPF Envoy Medical Acclaim Implant Trial Hits Key Milestone Labcorp Enables KEYTRUDA Access with FDA Diagnostic PureTech Reports Positive LYT-200 Phase 1b Trial Data Biocon Gains Health Canada Nod for Denosumab Biosimilars Adial AD04 Manufacturing Milestone Supports Phase 3 Vapotherm Gains FDA Clearance for All Patient Circuit Device Polaryx Therapeutics Secures FDA Fast Track for PLX-200 in Rare Diseases Karyopharm SENTRY Trial Advances Myelofibrosis Treatment Cristcot NDA Accepted for ngHCA in Ulcerative Colitis Castle Biosciences DecisionDx Melanoma Improves Risk Prediction Johnson & Johnson IMAAVY Shows Strong Phase 3 gMG Data Dark Horse Consulting Expands Asia with CJ PARTNERS Deal Cellectar Biosciences Showcases Iopofosine Data at ASCO Thryv Therapeutics Targets LQTS with THRV-1268 Trial Launch IDEAYA Biosciences Darovasertib Combo Advances Uveal Melanoma Care Nuvalent ALKOVE-1 Data Boosts NSCLC Targeted Therapy Novo Nordisk Oral Semaglutide Shows Pediatric Breakthrough